PATENT CLAIM ANALYSIS

Application Number: 16062840
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "282000"]

Abstract:
An injectable liquid composition for the treatment of a physical addiction includes naltrexone in the amount of 5%-95% of the total weight of the composition; at least two co-polymers in the amount of between 5%-95% of the total weight of the composition; and a biocompatible water miscible organic solvent in the amount of 5% to 50% of the total weight of the composition. The composition is adapted to form a gel-like mass when contacted with an aqueous environment and to dissolve at a predetermined rate to release a therapeutic naltrexone dose over a predetermined period of time.

Claim (Index 17):
The method according to  claim 15  or the step of maintaining a blood concentration of naltrexone in a subject of between about 2 ng/ml and 2.5 ng/nl for a period of between 5 days to 90 days.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.94643
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10159559', '12788770', '15755374', '11527757', '15334000']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7259706996442103
- 35 USC 102 Novelty (BERT): 0.5032007175548457
- Combined Prediction Score: 0.7036937014352739
- Mean Citation Score: 204.197584
- Max Citation Score: 225.7069
- Similarity Product: 161.91536636095046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test